This website uses cookies to improve the site and user experience. By continuing to browse this site,
you agree to accept our use of cookies. For more information, please review our Cookies Policy
SITC 2021
Presentations
SGN-PDL1V | Solid Tumors | Poster #783
SGN-PDL1V, a novel, investigational PD-L1 directed antibody drug conjugate for the treatment of solid tumors